share_log

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

花旗集团以买入评级启动对Alpha Tau Medical的保险,宣布目标股价为8美元
Benzinga ·  2023/12/15 09:43

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $8.

花旗集团分析师阿希克·穆巴拉克以买入评级开始对Alpha Tau Medical(纳斯达克股票代码:DRTS)进行报道,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发